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Urosepsis with Actinobaculum schaalii and Aerococcus urinae
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Actinobaculum was isolated from urine only after prolonged incubation in 5% CO2 after discrepancy between
urine Gram stain and initial culture results was observed. Additional patients were diagnosed using this
method. The prevalence of Actinobaculum species in urinary tract infections is underestimated since it is not
isolated by routine urine culture procedures.
CASE REPORT
A 78-year-old man was admitted to the neurology ward with
a subdural hematoma and contusio cerebri following a fall. An
indwelling bladder catheter was placed because of urinary in-
continence from a coexisting delirium. After 3 weeks of admis-
sion, the patient developed an episode of fever with a temper-
ature of 39°C, nausea, vomiting, tachycardia, and hypertension.
C-reactive protein was 155 mg/liter, and leukocytes were 14.0
 109/liter (90% neutrophils). Urine microscopy of sedi-
mented urine showed more than 50 leukocytes and 25 to 50
erythrocytes per field (400), hyaline casts, and bacteria. A
urosepsis was assumed, and the patient was empirically treated
with ceftriaxone (1,000 mg every 24 h [q24h] intravenously)
and gentamicin (5 mg/kg q24h intravenously) for the first 48 h.
From both urine and blood collected on the same day, Acti-
nobaculum schaalii and Aerococcus urinae were cultured.
Gram stain of uncentrifuged urine showed gram-positive
rods and gram-positive cocci in clusters in the presence of
many leukocytes (20 leukocytes per field [100]) (Fig. 1).
Poor growth of gram-positive cocci was observed on blood agar
and MacConkey agar after overnight culture at 37°C in ambi-
ent air. The isolate was identified as Aerococcus species by
phenotypic tests (colony morphology, Gram stain morphology,
catalase, growth in 6.5% NaCl, pyrrolidonyl-arylamidase,
leucine-aminopeptidase, -glucuronidase, hippurate hydroly-
sis, and vancomycin susceptibility) and was confirmed to be
Aerococcus urinae by sequence analysis of 16S rRNA DNA.
Growth of gram-positive rods on blood agar and not Mac-
Conkey was present only after 48 h of reincubation at 37°C in
5% CO2. After subculture, growth was better on blood agar
than on chocolate agar. Growth was best in 5% CO2 and equal
under anaerobic conditions and in ambient air. After 24 h,
colonies were pinpoint. After 48 h, colonies were nonhemo-
lytic, dome-shaped, and glistening gray, with entire edges rang-
ing in size from 0.5 to 1 mm appearing as two separate isolates.
Catalase and oxidase reactions were negative. Motility by
hanging drop was negative. Gram stain of a 24-h liquid culture
(Brewer thioglycolate broth) showed irregular staining gram-
positive rods with a diphteroid appearance, including Chinese-
character configuration. Bacteria were nonspore-forming and
not acid fast with a modified Kinyoun stain or Ziehl-Neelsen
stain. The biochemical test results obtained with API Coryne
(API Laboratory Products, bioMerieux, France) were as fol-
lows: negative results for nitrate reduction; positive results for
pyrazinamidase, pyrrolidonyl arylamidase, and -glucosidase;
negative results for alkaline phosphatase, -glucuronidase,
-galactosidase, N-acetyl--glucosaminidase, urease, gelatin
hydrolysis, and esculine hydrolysis; and fermentation of ribose,
xylose, maltose, and sucrose. As in a previous report, the API
Coryne system resulted in profile code 6010621, associated
with poor identification of Gardnerella vaginalis (6). The ab-
sence of beta-hemolysis on agar containing human blood and
resistance to metronidazole were inconsistent with this identi-
fication. 16S rRNA gene sequence analysis showed 99% se-
quence similarity with A. schaalii. A. urinae and A. schaalii were
also isolated from blood, each separately, from the anaerobic
bottle of two blood culture sets after 24 and 48 h incubation,
respectively, using the BACTEC 9240 (Becton Dickinson,
Cockeysville, Md.). In vitro susceptibility was performed by the
Kirby-Bauer disk diffusion method on Columbia blood agar in
5% CO2 using 0.5 McFarland inoculum. According to the
Clinical and Laboratory Standards Institute criteria for Strep-
tococcus spp., the isolate was susceptible to penicillin, amoxi-
cillin, ceftriaxone, tetracycline, clarithromycin, clindamycin, ni-
trofurantoin, and co-trimoxazole. No zone was present around
ciprofloxacin.
The patient responded well after 7 days of therapy with
ceftriaxone. The urinary catheter was removed, and treatment
was continued with 500 mg amoxicillin q6h orally for another
14 days, guided by the in vitro susceptibility results. A urologic
investigation that was performed because of persistent macro-
scopic hematuria 1 week after completion of treatment re-
vealed no signs of urinary tract obstruction or malignancy.
Cystoscopy showed a diffuse cystitis, and empirical treatment
was started with ciprofloxacin. This time, a urine culture
showed A. schaalii only. Blood cultures were not collected. The
patient’s symptoms improved after treatment with ciprofloxa-
cin. However, since the isolate showed in vitro resistance to
ciprofloxacin and urine cultures remained positive, ciprofloxa-
cin was switched to 960 mg co-trimoxazole q12h orally for
another 4 weeks under the presumptive diagnosis of chronic
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prostatitis. After completion of treatment, there were no symp-
toms of urinary tract infection. A urine specimen showed no
leukocytes, and the culture was negative.
Urinary tract infections are predominantly caused by mem-
bers of the family Enterobacteriaceae. However, gram-positive
bacteria and polymicrobial infections are not uncommon in
patients with complicated and nosocomial urinary tract infec-
tions (7).
The current case describes a dual infection of A. schaalii and
A. urinae in the urinary tract with bacteremia in an elderly man
with an indwelling urinary catheter. In recent years, A. urinae
has become an established albeit rare pathogen in urinary tract
infections predominantly in elderly patients and has been re-
ported to be a cause of sepsis and endocarditis as well (1, 9). In
contrast, cases of human infection with Actinobaculum species
are limited to a few reports (2–6, 8).
Actinobaculum is a gram-positive rod closely related to the
genus Actinomyces and was first described as a cause of human
infection in 1997 (5). Currently, four species within the genus
have been described, Actinobaculum suis, A. schaalii, Acti-
nobaculum massiliae, and A. urinale, and the latter three have
been described in cases of human infection for six patients. In
one patient, the organism was isolated from a skin abscess (8).
It was cultured from urine in two patients with cystitis and one
with pyelonephritis (3, 4, 6). Actinobaculum was isolated from
blood in a patient with chronic pyelonephritis and a patient
with chronic renal failure (2, 5). In the latter two patients, the
urinary tract was identified as a possible source of bacteremia
but was not confirmed microbiologically.
In the current case, A. schaalii was cultured from both urine
and blood, which shows it to be a uropathogen with invasive
potential. As in the previous reports, Actinobaculum was iso-
lated from urine only after prolonged incubation in 5% CO2,
which was done because of the discrepancy between urine
Gram stain and initial culture results. As in most laboratories,
routine urine cultures are incubated only overnight at 37°C in
ambient air using Columbia blood agar and MacConkey agar.
Thus, the dual infection of the urinary tract and the source of
the bacteremia with A. schaalii would have been missed with-
out routine Gram stain of the urine, which was recently intro-
duced in our laboratory. Although routine urine Gram stain
may not be cost-effective in most laboratory settings, it may be
an important diagnostic adjunct in selected patients with a high
suspicion of urinary tract infection and a negative routine uri-
nary culture. Over a 6-month period, prolonged incubation in
5% CO2 of urine that showed significant leucocyturia and
gram-positive rods on microscopy in the absence of contami-
nation resulted in four additional cases of urinary tract infec-
tion with A. schaalii (n  2), A. urinale, and A. massiliae. All
four patients were males between 38 and 90 years of age with
underlying urological conditions, i.e., longstanding lower uri-
nary tract symptoms of unknown origin, neurogenic bladder
due to paralysis for which intermittent catheterization was
needed (n 2), and urethra stricture due to lichen sclerosus et
atrophicus.
The delayed growth of gram-positive rods on blood agar
after incubation in 5% CO2 or under anaerobic conditions
from urine with significant pyuria and of gram-positive rods on
urine Gram stain is suggestive of infection with Actinobaculum
spp. Although the growth of the isolate described here was
stimulated by CO2, others have reported Actinobaculum to be
an aerotolerant anaerobic bacterium (2, 8). The API Coryne
system can be used to further characterize such isolates. The
test results obtained with API Coryne were in keeping with the
biochemical characteristics of A. schaalii that have been sum-
marized in previous reports, including the negative urease test
which distinguishes A. schaalii from A. urinale (2, 3, 6).
Besides the importance of making a clinical and microbio-
logical diagnosis in a patient, it is important to be informed on
the prevalence of the various etiologies of urinary tract infec-
tion in specific patient groups and their susceptibility to the
antimicrobials used. In this case, the A. schaalii isolate, which
was susceptible in vitro to most of the drugs commonly used for
urinary tract infections, was resistant to ciprofloxacin, which is
a first-line antibiotic in the treatment of prostatitis. All four
additional isolates were susceptible to the beta-lactam antibi-
otics, tetracycline and nitrofurantoin; two were resistant to
co-trimoxazole; and one was intermediate susceptible to clar-
ithromycin and resistant to clindamycin. The inhibition zones
around ciprofloxacin were 40 mm, 18 mm (two isolates), and 6
mm (no zone).
In conclusion, this report adds five additional patients to the
six published cases of Actinobaculum infection since its first
description as a cause of human infection in 1997 (5). Acti-
nobaculum infections appear to occur in patients with under-
lying urological pathology. Since there are only a few reports,
the invasive potential of Actinobaculum is likely to be limited.
However, the prevalence of Actinobaculum species in urinary
tract infections is underestimated since it is not isolated by
routine urine culture procedures, and routine urine Gram stain
FIG. 1. A Gram stain of uncentrifuged urine shows gram-positive
rods and gram-positive cocci in clusters in the presence of many leu-
kocytes (magnification, 1,000).
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is not performed in many laboratories. Urine Gram stain is an
important diagnostic tool for patients with a high suspicion of
urinary tract infection but negative routine urinary culture,
especially in the presence of structural abnormalities of the
urinary tract.
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